| Title |
Anaphylaxis following quadrivalent human papillomavirus vaccination
|
|---|---|
| Published in |
Canadian Medical Association Journal, September 2008
|
| DOI | 10.1503/cmaj.080916 |
| Pubmed ID | |
| Authors |
Julia M L Brotherton, Mike S Gold, Andrew S Kemp, Peter B McIntyre, Margaret A Burgess, Sue Campbell-Lloyd |
| Abstract |
In 2007, Australia implemented the National human papillomavirus (HPV) Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12-26 years. Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, Australia, we verified cases and compared the incidence of anaphylaxis following HPV vaccination to other vaccines in comparable settings. |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 23% |
| Japan | 2 | 6% |
| Spain | 1 | 3% |
| United Kingdom | 1 | 3% |
| Canada | 1 | 3% |
| Unknown | 19 | 61% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 28 | 90% |
| Practitioners (doctors, other healthcare professionals) | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 2% |
| Belgium | 1 | 2% |
| Denmark | 1 | 2% |
| Spain | 1 | 2% |
| United States | 1 | 2% |
| Unknown | 53 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 16% |
| Student > Master | 7 | 12% |
| Student > Doctoral Student | 6 | 10% |
| Student > Bachelor | 4 | 7% |
| Professor | 4 | 7% |
| Other | 13 | 22% |
| Unknown | 15 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 52% |
| Agricultural and Biological Sciences | 3 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Social Sciences | 2 | 3% |
| Nursing and Health Professions | 1 | 2% |
| Other | 4 | 7% |
| Unknown | 16 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2024.
All research outputs
#949,280
of 25,758,695 outputs
Outputs from Canadian Medical Association Journal
#1,396
of 9,547 outputs
Outputs of similar age
#1,932
of 96,535 outputs
Outputs of similar age from Canadian Medical Association Journal
#7
of 51 outputs
Altmetric has tracked 25,758,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,547 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,535 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.